316 related articles for article (PubMed ID: 32810868)
1. Point-of-Care Testing for Sexually Transmitted Infections: A Review of Recent Developments.
Adamson PC; Loeffelholz MJ; Klausner JD
Arch Pathol Lab Med; 2020 Nov; 144(11):1344-1351. PubMed ID: 32810868
[TBL] [Abstract][Full Text] [Related]
2. Point of care diagnostics for sexually transmitted infections: perspectives and advances.
Gaydos C; Hardick J
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):657-72. PubMed ID: 24484215
[TBL] [Abstract][Full Text] [Related]
3. Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and
Cordioli M; Gios L; Mirandola M; Zorzi A; Barbara C; Padovese V; Hancali A; Oumzi H; Kularatne R; Jiang TT; Caceres CF; Vargas S; Alvarez CS; Camey E; Peeling RW; Unemo M; Ballard R; Blondeel K; Kiarie J; Thwin SS; Toskin I;
BMJ Open; 2024 Jun; 14(6):e073565. PubMed ID: 38885995
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
Herbst de Cortina S; Bristow CC; Joseph Davey D; Klausner JD
Infect Dis Obstet Gynecol; 2016; 2016():4386127. PubMed ID: 27313440
[TBL] [Abstract][Full Text] [Related]
5. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea.
Badman SG; Vallely LM; Toliman P; Kariwiga G; Lote B; Pomat W; Holmer C; Guy R; Luchters S; Morgan C; Garland SM; Tabrizi S; Whiley D; Rogerson SJ; Mola G; Wand H; Donovan B; Causer L; Kaldor J; Vallely A
BMC Infect Dis; 2016 Jun; 16():250. PubMed ID: 27268218
[TBL] [Abstract][Full Text] [Related]
6. [Frequency of curable sexually transmitted infections among registered female sex-workers in Ankara City].
Zarakolu P; Alp S; Yağci S
Mikrobiyol Bul; 2010 Jan; 44(1):117-21. PubMed ID: 20455407
[TBL] [Abstract][Full Text] [Related]
7. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections.
Toskin I; Govender V; Blondeel K; Murtagh M; Unemo M; Zemouri C; Peeling RW; Kiarie J
Sex Transm Infect; 2020 Aug; 96(5):342-347. PubMed ID: 32241905
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.
Garland SM; Tabrizi SN; Chen S; Byambaa C; Davaajav K
Infect Dis Obstet Gynecol; 2001; 9(3):143-6. PubMed ID: 11516062
[TBL] [Abstract][Full Text] [Related]
9. Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis.
Toskin I; Murtagh M; Peeling RW; Blondeel K; Cordero J; Kiarie J
Sex Transm Infect; 2017 Dec; 93(S4):S69-S80. PubMed ID: 29223965
[TBL] [Abstract][Full Text] [Related]
10. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis.
Fortenberry JD; Brizendine EJ; Katz BP; Wools KK; Blythe MJ; Orr DP
Sex Transm Dis; 1999 Jan; 26(1):26-32. PubMed ID: 9918320
[TBL] [Abstract][Full Text] [Related]
11. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.
Natoli L; Guy RJ; Shephard M; Whiley D; Tabrizi SN; Ward J; Regan DG; Badman SG; Anderson DA; Kaldor J; Maher L;
BMJ Open; 2015 Apr; 5(4):e006922. PubMed ID: 25922100
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward.
Wi TE; Ndowa FJ; Ferreyra C; Kelly-Cirino C; Taylor MM; Toskin I; Kiarie J; Santesso N; Unemo M
J Int AIDS Soc; 2019 Aug; 22 Suppl 6(Suppl Suppl 6):e25343. PubMed ID: 31468679
[TBL] [Abstract][Full Text] [Related]
13. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus.
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
Clin Microbiol Infect; 2018 Dec; 24(12):1328-1332. PubMed ID: 29559392
[TBL] [Abstract][Full Text] [Related]
14. A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States.
Gaydos CA; Manabe YC; Melendez JH
Sex Transm Dis; 2021 Aug; 48(8S):S71-S77. PubMed ID: 34110728
[TBL] [Abstract][Full Text] [Related]
15. Sexually Transmitted Infection Point-of-Care Testing in Resource-Limited Settings: A Narrative Review Guided by an Implementation Framework.
Chitneni P; Owembabazi M; Muyindike W; Asiimwe S; Masete G; Mbalibulha Y; Nakku-Joloba E; Manabe YC; Haberer JE; Matthews LT; Van Der Pol B
Sex Transm Dis; 2023 Oct; 50(10):e11-e16. PubMed ID: 37433000
[TBL] [Abstract][Full Text] [Related]
16. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025.
Chemtob D; Gandacu D; Mor Z; Grotto I; Anis E; Rosenberg E
Isr J Health Policy Res; 2017; 6():23. PubMed ID: 28428838
[TBL] [Abstract][Full Text] [Related]
17. Sexually transmitted infections other than HIV/AIDS among women of low socio-economic class attending antenatal clinics in Khartoum, Sudan.
Abdelrahim NA; Ahmed HI; Fadl-Elmula IM; Bayoumi MA; Homeida MM
Int J STD AIDS; 2017 Jul; 28(8):781-787. PubMed ID: 27582306
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of rapid tests for sexually transmitted infections in symptomatic women.
Nuñez-Forero L; Moyano-Ariza L; Gaitán-Duarte H; Ángel-Müller E; Ruiz-Parra A; González P; Rodríguez A; Tolosa JE
Sex Transm Infect; 2016 Feb; 92(1):24-8. PubMed ID: 26136508
[TBL] [Abstract][Full Text] [Related]
19. A multiplex PCR assay for the simultaneous detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.
Abou Tayoun AN; Burchard PR; Caliendo AM; Scherer A; Tsongalis GJ
Exp Mol Pathol; 2015 Apr; 98(2):214-8. PubMed ID: 25595915
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.
Boiko I; Golparian D; Krynytska I; Unemo M
APMIS; 2019 Sep; 127(9):627-634. PubMed ID: 31225920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
